Resynthesis of Potential Therapeutic Agents - Jaroslav Novotny

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research and Development Contracts (N01)
Project #: N01AI055256-001
Application #: 2296428
Study Section

Project Start: 1994-10-26
Project End: 1999-10-25
Budget Start: 1995-01-04
Budget End: 1995-10-25
Support Year
Fiscal Year: 1995
Total Cost
Indirect Cost

Institution

Name: Starks Associates, Inc.
Department
Type
DUNS #

City: Buffalo
State: NY
Country: United States
Zip Code: 14213

Related projects


NIH 1999 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Juroslov / Starks Associates, Inc.
NIH 1999 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Juroslov / Starks Associates, Inc.
NIH 1997 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Jaroslav / Starks Associates, Inc.
NIH 1996 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Jaroslav / Starks Associates, Inc.
NIH 1995 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Jaroslav / Starks Associates, Inc.
NIH 1995 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Jaroslav / Starks Associates, Inc.
NIH 1995 N01 AI	Resynthesis of Potential Therapeutic Agents Novotny, Jaroslav / Starks Associates, Inc.

Publications

Chio, L C; Bolyard, L A; Nasr, M et al. (1996) Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium. Antimicrob Agents Chemother 40:727-33

Comments

Be the first to comment on Jaroslav Novotny's grant